학술논문
Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study.
Document Type
Article
Author
Source
HIV Research & Clinical Practice; Dec2023, Vol. 24 Issue 1, p1-6, 6p
Subject
Language
ISSN
25787489
Abstract
Copyright of HIV Research & Clinical Practice is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)